Sponsor:
Taiho Oncology, Inc.
Code:
NCT05727176
Conditions
Advanced Cholangiocarcinoma
FGFR2 Fusions
Gene Rearrangement
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TAS-120
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Taiho Oncology, Inc. on 2025-04-02.